VentrAssist左心室辅助系统首次作为终末期心力衰竭的目标治疗进行临床植入。
First clinical implant of the VentrAssist left ventricular assist system as destination therapy for end-stage heart failure.
作者信息
Esmore Donald S, Kaye David, Salamonsen Robert, Buckland Mark, Rowland Michael, Negri Justin, Rowley Yvonne, Woodard John, Begg John R, Ayre Peter, Rosenfeldt Franklin L
机构信息
Department of Cardiothoracic Surgery, Alfred Hospital, Prahran, Victoria, Australia.
出版信息
J Heart Lung Transplant. 2005 Aug;24(8):1150-4. doi: 10.1016/j.healun.2005.01.014.
The VentrAssist device left ventricular assist system, designed for permanent implantation, is a novel centrifugal pump with a hydrodynamically suspended rotor. The first human implant was into a 72-year-old man with New York Heart Association (NYHA) class IV heart failure due to idiopathic dilated cardiomyopathy. The implant and recovery were uneventful, and the patient survives at 17 months, is NYHA class II, and lives at home. This device shows promise in end-stage heart failure for permanent implantation and bridge to transplantation.
VentrAssist 装置是一种专为永久植入设计的左心室辅助系统，是一种带有流体动力学悬浮转子的新型离心泵。首例人体植入手术是针对一名 72 岁因特发性扩张型心肌病导致纽约心脏协会（NYHA）IV 级心力衰竭的男性患者。植入过程及恢复情况均顺利，患者存活了 17 个月，心功能为 NYHA II 级，且在家中生活。该装置在终末期心力衰竭的永久植入及过渡到移植方面显示出前景。
Zotero 插件